Company Announcements

Clariant AG: Impairment of bioethanol plant in Romania

Source: OMX
Clariant AG: Impairment of bioethanol plant in Romania



  • Asset impairment of approximately CHF 225 million relating to Clariant’s bioethanol plant in Podari, Romania
  • Planned commercialization and optimization process of the plant continue with the aim to industrialize the sunliquid® technology
  • Clariant confirms the unique value of its second-generation bio-based cellulosic ethanol solutions


Clariant, a focused, sustainable, and innovative specialty chemical company, today announced a financial impairment of its sunliquid® plant in Podari, Romania, amounting to approximately CHF 225 million.

As previously reported, the sunliquid® plant began production in the second quarter of 2022, though has not yet achieved the targeted yields and other operational parameters on an industrial scale. Clariant has thus completed a financial assessment of the plant as part of the annual impairment testing in accordance with International Financial Reporting Standards (IFRS). As a result of this analysis, Clariant has concluded that an impairment to the current asset value of the Podari plant of approximately CHF 225 million is appropriate based on the delayed ramp up and the current financial performance.

Clariant confirms the unique value of the sunliquid® technology and will continue its commercialization. Clariant aims to address the operational challenges by continuously adjusting production processes with the target of achieving commercial viability of the new technology.

“Our sunliquid® technology, which converts agricultural waste into second generation bioethanol, represents a significant step in the development of sustainable renewable fuel. The industrialization of our new technology remains challenging, and therefore impacts underlying financial assumptions, giving rise to the impairment announced today. Nonetheless, we will continue our efforts to achieve commercial viability of the technology,” said Conrad Keijzer, Chief Executive Officer of Clariant.

“While we are disappointed by this impairment, we are however pleased with our strong Group financial performance in the first three quarters of 2022. Consequently, we confirm our 2025 financial targets and continue to focus on the execution of our leading purpose-driven sustainability strategy,” added Keijzer.

This impairment has no impact on cash, will be booked in December 2022 and will, therefore, be reflected in the full year 2022 results, due to be announced on 2 March 2023.


Background on the Podari plant

Construction of the sunliquid® plant was completed in October 2021 and it began production in the second quarter of 2022. The cellulosic ethanol produced at this plant can be applied as a drop-in solution for fuel blending, but also offers further downstream application opportunities for sustainable aviation fuel and bio-based chemicals. Its sunliquid® technology offers a fully integrated process design built on established process technology. Innovative technology features include chemical-free pre-treatment, the integrated production of feedstock- and process-specific enzymes and simultaneous C5 and C6 sugar fermentation.



Jochen Dubiel
Phone +41 61 469 63 63


Anne Maier
Phone +41 61 469 63 63


Ellese Caruana
Phone +41 61 469 63 63



Andreas Schwarzwälder
Phone +41 61 469 63 73


Maria Ivek
Phone +41 61 469 63 73


Thijs Bouwens
Phone +41 61 469 63 73
Follow us on Twitter, Facebook, LinkedIn, Instagram.


This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the Company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials.



Clariant is a focused, sustainable, and innovative specialty chemical company based in Muttenz, near Basel/Switzerland. On 31 December 2021, Clariant totaled a staff number of 11 537 and recorded sales of CHF 4.372 billion in the fiscal year for its continuing businesses. The company reports in three Business Areas: Care Chemicals, Catalysis, and Natural Resources. Clariant’s corporate strategy is led by the overarching purpose of ‘Greater chemistry – between people and planet,’ and reflects the importance of connecting customer focus, innovation, sustainability, and people.